Evaluation of actinomycins in experimental systems.
D000818:Animals; D001215:Asparaginase / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy; D003429:Cross Reactions; D003609:Dactinomycin / Q000009:adverse effects / Q000096:biosynthesis / Q000138:chemical synthesis / Q000627:therapeutic use*; D004341:Drug Evaluation; D004359:Drug Therapy, Combination; D004640:Emetine / Q000627:therapeutic use; D007939:Leukemia L1210 / Q000188:drug therapy; D007942:Leukemia, Experimental / Q000188:drug therapy; D008175:Lung Neoplasms / Q000188:drug therapy; D008545:Melanoma / Q000188:drug therapy; D051379:Mice; D008815:Mice, Inbred Strains; D013302:Streptomyces / Q000378:metabolism; D014750:Vincristine / Q000627:therapeutic use
D003609:Dactinomycin; D014750:Vincristine; D001215:Asparaginase; D004640:Emetine